Research Analysts Offer Predictions for CLB Q1 Earnings

Core Laboratories Inc. (NYSE:CLB - Free Report) - Stock analysts at Zacks Research issued their Q1 2025 earnings estimates for Core Laboratories in a research note issued on Wednesday, March 26th. Zacks Research analyst T. Saha expects that the oil and gas company will post earnings per share of $0.15 for the quarter. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories' Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.83 EPS, Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.28 EPS and FY2026 earnings at $1.04 EPS.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

Separately, Citigroup upgraded shares of Core Laboratories from a "sell" rating to a "neutral" rating and raised their target price for the stock from $15.00 to $16.00 in a report on Wednesday, March 12th. One analyst has rated the stock with a sell rating and four have issued a hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $17.50.

Core Laboratories Stock Down 9.9 %

NYSE:CLB traded down $1.48 during trading hours on Monday, reaching $13.44. 694,091 shares of the company traded hands, compared to its average volume of 373,647. Core Laboratories has a 1 year low of $12.77 and a 1 year high of $25.13. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The business's 50-day moving average price is $16.01 and its two-hundred day moving average price is $18.03. The stock has a market capitalization of $629.35 million, a P/E ratio of 20.36, a P/E/G ratio of 0.99 and a beta of 2.38.

Institutional Trading of Core Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Confluence Investment Management LLC grew its stake in Core Laboratories by 0.4% in the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock worth $2,360,000 after purchasing an additional 599 shares in the last quarter. Isthmus Partners LLC raised its holdings in shares of Core Laboratories by 5.6% in the fourth quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company's stock valued at $194,000 after acquiring an additional 599 shares in the last quarter. Tidal Investments LLC boosted its stake in shares of Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock valued at $813,000 after purchasing an additional 716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Core Laboratories by 3.7% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company's stock valued at $463,000 after acquiring an additional 960 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock worth $35,000 after purchasing an additional 1,293 shares during the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were given a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a yield of 0.30%. Core Laboratories's dividend payout ratio is presently 6.06%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.